100 Participants Needed

Cognitive Training + Electroacupuncture for Fibromyalgia

Recruiting at 2 trial locations
SE
AG
Overseen ByArvina Grahl, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Spaulding Rehabilitation Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore a new non-drug approach to managing fibromyalgia pain. Participants will receive either cognitive training, which involves learning pain management techniques from a pain specialist, or education training about fibromyalgia. The study will also examine how these treatments affect the brain's response to pain. It suits individuals who have experienced moderate to severe fibromyalgia pain for at least six months and are on stable medication. As an unphased trial, this study offers a unique opportunity to contribute to innovative research and potentially enhance personal pain management strategies.

Will I have to stop taking my current medications?

No, you will not have to stop taking your current medications. Participants must be on stable doses of medication for 30 days before the study and agree not to change medications or dosages during the trial.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that cognitive training is generally safe for people with fibromyalgia. One type, cognitive behavioral therapy, is effective and well-received by patients. Studies have found that it can reduce pain and improve quality of life without causing major side effects.

Electroacupuncture, similar to traditional acupuncture but with a small electrical current, has been compared with other fibromyalgia treatments. Research suggests it is safe and may help relieve pain. No major safety issues have been reported, though further research could provide clearer insights into its benefits.

Both treatments have a history of being well-tolerated, which is encouraging for those considering joining the trial.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a novel combination of cognitive training and electroacupuncture for managing fibromyalgia. Unlike typical treatments, which often include medications like antidepressants or pain relievers, electroacupuncture uses targeted electrical stimulation to potentially reduce pain more effectively and naturally. Cognitive training adds another layer by helping patients develop skills to better manage their pain perception and response. This dual approach could offer a more holistic way to tackle fibromyalgia, possibly leading to improved quality of life for sufferers.

What evidence suggests that this trial's treatments could be effective for fibromyalgia?

This trial will compare Cognitive Training with Education Training for fibromyalgia. Research has shown that brain exercises, such as those used in Cognitive Training, can reduce pain and improve mood in people with fibromyalgia. Studies have found that combining these exercises with other treatments can significantly ease pain and symptoms like anxiety and depression. Cognitive behavioral therapy (CBT), a type of brain exercise, is often recommended as a primary treatment for fibromyalgia due to its effectiveness and general tolerability. Electroacupuncture, which combines acupuncture with mild electrical stimulation, may help by affecting pain pathways in the body. Early research suggests that electroacupuncture can lower pain levels and enhance overall well-being for those with fibromyalgia.14678

Who Is on the Research Team?

Vitaly Napadow, Ph.D. — Innovation ...

Vitaly Napadow, PhD

Principal Investigator

Spaulding Rehabilitation Hospital

Are You a Good Fit for This Trial?

This trial is for individuals with Myofascial Pain Syndrome or Fibromyalgia who meet specific criteria, have a pain intensity of at least 4/10, and have been in pain for over six months. Participants must be on stable medication doses and agree not to change them during the study. They can't join if they work in pain treatment, have certain mental health conditions, contraindications to fMRI scans like metal implants or pacemakers, use opioids, or are pregnant.

Inclusion Criteria

Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
My pain level is at least a 4 out of 10.
I have been experiencing pain for at least 6 months.
See 2 more

Exclusion Criteria

Inability to respond accurately to the pain-relieving intervention in the behavioral part of the experiment, indicating a lack of response to the expectancy manipulation. If the healthy volunteer or clinician is not a responder to the behavioral expectancy induction he or she will be excluded
Documented peripheral neuropathy
Pregnant
See 18 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Cognitive Training

Participants will meet with a pain specialist who will conduct a specific form of cognitive training targeting fibromyalgia.

Up to 6 months

Education Training

Participants will meet with a pain specialist to receive education training related to fibromyalgia.

Up to 6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Electroacupuncture
  • Training
Trial Overview The trial tests cognitive training combined with electroacupuncture to see if it improves brain coordination and reduces chronic pain. It's non-drug-based and follows recommendations for managing chronic pain. The study will also explore how therapeutic relationships affect pain outcomes using neural models.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive TrainingExperimental Treatment2 Interventions
Group II: Education TrainingActive Control2 Interventions

Electroacupuncture is already approved in China, United States, European Union for the following indications:

🇨🇳
Approved in China as Electroacupuncture for:
🇺🇸
Approved in United States as Electroacupuncture for:
🇪🇺
Approved in European Union as Electroacupuncture for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Spaulding Rehabilitation Hospital

Lead Sponsor

Trials
143
Recruited
11,200+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

Cognitive-behavioral therapy (CBT) is effective in teaching patients skills to manage pain and disability, showing promise for individuals with primary fibromyalgia, similar to its success in back pain and rheumatoid arthritis.
The article outlines experimental designs for randomized controlled trials of CBT in fibromyalgia patients, emphasizing the need for specific methodological features to ensure robust results.
Cognitive-behavioral therapy for primary fibromyalgia.Bradley, LA.[2019]
Fibromyalgia is linked to central nervous system hypersensitivity and involves various genetic and environmental factors, leading to significant morbidity and high treatment costs despite existing therapies.
Emerging noninvasive brain stimulation techniques, like transcranial direct current stimulation and transcranial magnetic stimulation, show promise as potential treatments for fibromyalgia pain, but further research is necessary to establish their efficacy.
Non-invasive brain stimulation approaches to fibromyalgia pain.Short, B., Borckardt, JJ., George, M., et al.[2021]
Transcranial alternating current stimulation (tACS) combined with physiotherapy significantly reduced pain and improved cognitive symptoms in patients with fibromyalgia syndrome (FMS), as evidenced by clinical assessments conducted on 15 participants over a 2-week period.
EEG results showed that tACS increased alpha1 brain wave activity, which correlated with improvements in self-reported cognitive skills and neuropsychological scores, indicating that tACS may effectively modulate abnormal brain activity associated with FMS.
Beyond physiotherapy and pharmacological treatment for fibromyalgia syndrome: tailored tACS as a new therapeutic tool.Bernardi, L., Bertuccelli, M., Formaggio, E., et al.[2022]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39327324/
Cognitive training and physical therapy for fibromyalgiaAdding cognitive training to a standard physical-medical clinical therapy resulted in significant pain relief and improvement of depression in ...
Effectiveness of the FIBROWALK multicomponent therapy ...This study supports the short-term effectiveness of FIBROWALK in both formats, and mid-term reduction of fibromyalgia severity and pain in the ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/21258823/
[Medium-term effects of a multimodal therapy on patients ...Results: The intervention group showed better results regarding symptoms (pain intensity, anxiety, depression), state of health (somatic health, psychological ...
Effectiveness of two video-based multicomponent ...The FIBROWALK intervention showed superior effects in improving pain, anxiety and depressive symptoms and physical functioning compared to MPP.
CBT and Mindfulness-Based Therapies for FibromyalgiaCognitive behavioral therapy is a first-line treatment for fibromyalgia, based on data demonstrating its efficacy and tolerability among this ...
The Efficacy and Safety of Telerehabilitation for FibromyalgiaThe results of this meta-analysis indicated that telerehabilitation can improve the FIQ score, pain intensity, depression, and QoL in patients ...
A safety and feasibility randomized placebo controlled trial ...This study evaluates the safety, feasibility, and acceptability of a novel electroencephalography-based neurofeedback training, targeting effective alpha-band ...
Mind-body therapy for treating fibromyalgia: a systematic reviewWith the exception of mindfulness-based stress reduction, all therapies had at least 1 study showing significant improvements in pain at the end of treatment.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security